Hsu S.-L.HSUEH-WEN HSUEHChen S.-Y.Chang Y.-Y.Tan S.Hong C.-T.Tsai Y.-S.Yu K.-W.Wu H.-M.Liao Y.-C.Soong B.-W.Hu C.-J.Lan M.-Y.Lee Y.-C.2021-11-112021-11-11202113538020https://www.scopus.com/inward/record.uri?eid=2-s2.0-85106285142&doi=10.1016%2fj.parkreldis.2021.05.004&partnerID=40&md5=495ffcbe64d87f926ff9e586e2771b40https://scholars.lib.ntu.edu.tw/handle/123456789/586648Aim: To investigate the clinical and genetic features of hereditary spastic paraplegia (HSP) type 3A (SPG3A) in Taiwan. Methods: Mutational analysis of the ATL1 gene was performed for 274 unrelated Taiwanese HSP patients. The diagnosis of SPG3A was ascertATL1; Atlastin-1; Hereditary spastic paraplegia; HSP; SPG3A[SDGs]SDG3adolescent; adult; aged; allele; Article; atlastin 1 gene; brain; child; clinical evaluation; clinical feature; cohort analysis; disability; disease severity; electrophysiology; female; founder effect; functional status assessment; gene; gene frequency; gClinical and genetic characterization of hereditary spastic paraplegia type 3A in Taiwanjournal article10.1016/j.parkreldis.2021.05.004340156942-s2.0-85106285142